课题基金 / 基金详情

Long noncoding RNA expressing genomic element that control antibody diversification and chromosomal integrity in B cells

Long noncoding RNA expressing genomic element that control antibody diversification and chromosomal integrity in B cells
表达控制 B 细胞抗体多样化和染色体完整性的基因组元件的长非编码 RNA
批准号:
10303057
负责人:
Uttiya Basu
金额:
$47.94万
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-12-07 至 2022-12-31

项目摘要

项目成果

Uttiya Basu的其他基金

相似基金

相关文献

中文摘要
翻译
项目总结/摘要 越来越明显的是,大多数哺乳动物基因组都有可能 表达非编码RNA(ncRNA)。然而,监管的职能和机制 这些非编码RNA才刚刚开始被探索。生物学家遇到的一个挑战是 这些ncRNA的检测通常在转录上受到严格控制且速度快 退化了我们最近发现了一个长的非编码(lnc)RNA表达位点,称为 lncRNA-CSR,调节B的免疫球蛋白重链(IgH)基因座中的DNA表达 细胞使用缺乏lncRNA加工/降解活性沿着有 结合高通量基因组学、生物信息学和各种基于ChIP-seq的 实验中,我们能够预测lncRNA-CSR的远程转录增强子功能, 基因座在本申请中,我们继续将研究重点放在lncRNA-CSR的功能上, 以及其他三个新的lncRNA表达位点,我们认为它们在协调DNA 生殖中心驻留B细胞中的再感染事件。B淋巴细胞具有独特的能力, 进行其基因组的程序性体细胞诱变(在免疫球蛋白基因座处), 产生我们的免疫系统所需的抗体的多样性,以对抗过多的 我们可能遇到的抗原,这一过程被称为抗体多样化。但是,作为抵押品, 这种非常不寻常的和有用的能力,进行有益的身体损害出现 诱变事件是B细胞以非常低的频率意外地使其基因组突变的能力 在各种不合适的地方这些偶然的突变是各种B细胞 恶性肿瘤,特别是从生发中心衍生的B细胞进化而来的那些。有趣的是, 在B细胞中,致癌易位发生在趋异转录区域,即启动子 和增强子-其存在于超增强子簇的拓扑结构域内部。我们推测 lncRNA-CSR负责栓系远距离调节元件(即启动子和 增强子),以促进基因组的组织,转录 控制受调控的基因,并最终促进抗体多样化机制, 诱发癌症导致DNA改变
英文摘要
PROJECT SUMMARY/ ABSTRACT It is becoming increasingly evident that the majority of the mammalian genome has the potential to express non-coding RNAs (ncRNAs). However, the functionality and mechanism(s) of regulation of these ncRNAs are just beginning to be explored. One challenge that biologists encounter is the detection of these ncRNAs, which often tend to be transcriptionally tightly controlled and rapidly degraded. We have recently identified a long noncoding (lnc) RNA expressing locus, known as lncRNA-CSR, that regulates DNA rearrangments in the Immunoglobulin heavy chain (IgH) locus of B cells. Using mouse model systems that lack lncRNA processing/degradation activity along with a combination with high throughput genomics, bioinformatics, and various ChIP-seq based experiments, we are able to predict long-range transcription enhancer function of the lncRNA-CSR locus. In this application, we continue to focus our investigation on the functionality of lncRNA-CSR and three other novel lncRNA expressing loci, that we propose to have a role in orchestrating DNA rearrangment events in germinal center resident B cells. B lymphocytes have the unique ability to undergo programmed somatic mutagenesis of their genomes (at immunoglobulin gene loci) to generate the diversity of antibodies required by our immune system to combat the plethora of antigens we might encounter, a process known as antibody diversification. However, as collateral damage emerging from this very unusual and useful ability to undertake beneficial somatic mutagenesis events is the ability of B cells accidently to mutate their genome at a very low frequency at various inappropriate locations. These accidental mutations are the cause of various B cell malignancies, particularly those that evolve from germinal center derived B cells. Interestingly, cancer-causing translocations in B cells occur at regions of divergent transcription—that is, promoters and enhancers—which exist inside topological domains of superenhancer clusters. We postulate that lncRNA-CSR is responsible for tethering long distant regulatory elements (i.e, promoters and enhancers) in the IgH locus superenhancer cluster to facilitate genome organization, transcription control of regulated genes, and, ultimately, to promote antibody diversification mechanisms without inducing cancer causing DNA alterations.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
FASEB's "The RNA Associated Mechanisms Conference: In Immunity and Disease"
The role of N6-methyladenosine RNA modification in programmed and aberrant DNA mutagenesis in B cells
The role of N6-methyladenosine RNA modification in programmed and aberrant DNA mutagenesis in B cells
The role of N6-methyladenosine RNA modification in programmed and aberrant DNA mutagenesis in B cells
海外基金